Corticosteroid Pulse After Ablation

Completed · Phase 4 · Has a placebo group

Conditions studied: Atrial Fibrillation

In brief

Radiofrequency ablation is an effective treatment for atrial fibrillation. However, about 20% of the time the atrial fibrillation recurs. Steroids given after the ablation may decrease inflammation caused by the ablation and thus improve healing and decrease the chance of recurrence of atrial fibrillation. In this study patients will be randomized to receive intravenous steroids or not immediately following the ablation.

Key facts

Study ID

NCT00807586

Run by

Minneapolis Heart Institute Foundation

People needed

119

Starts

2008-12-01

Expected to finish

2013-12-01

Last updated by the study team

2019-08-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18
• Drug refractory, symptomatic paroxysmal atrial fibrillation

You may not qualify if…

• Contraindication to solumedrol
• Persistent or permanent Atrial Fibrillation
• Previous history of radiofrequency ablation for atrial fibrillation

Where it is running

• Abbott Northwestern Hospital — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.